Liquidia Technologies recent IPO is great news for our investors who participated in their pre-IPO round on our platform in 2017. The US biopharmaceutical firm who raised S$27m in pre-IPO funding on our platform in 2017 announced its IPO pricing today.
“The pricing of its initial public offering of 4,545,455 shares of common stock are at a public offering price of $11.00 per share, before underwriting discounts and commissions, for gross proceeds of $50.0 million. In addition, the Company has granted the underwriters a 30-day option to purchase up to 681,818 additional shares of common stock at the initial public offering price, less the underwriting discount. The Company’s common stock is expected to begin trading on the Nasdaq Capital Market under the ticker symbol “LQDA” on July 26, 2018. The offering is expected to close on July 30, 2018 subject to customary closing conditions.”
Read the official NASDAQ announcement: